StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Down 12.5 %
Shares of NASDAQ SRNE opened at $0.00 on Friday. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.08.
About Sorrento Therapeutics
Recommended Stories
- Five stocks we like better than Sorrento Therapeutics
- What is a penny stock? A comprehensive guide
- Is Myers Industries Poised for a Breakout?
- Dividend Capture Strategy: What You Need to Know
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Which Wall Street Analysts are the Most Accurate?
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.